February 24, 2022
Branded Pharma Fee: Manufacturer Considerations
5 Minute Read
And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
Blog
February 15, 2022
Unifying IntegriChain’s Services & Support: Data Management
4 Minute Read
President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
February 3, 2022
Forecasting for the Future
2 Minute Read
How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
January 24, 2022
New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
January 20, 2022
IntegriChain and Blue Fin Group Combine Forces
2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
January 19, 2022
Best Practices: Redesigning the Perfect Launch
3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
January 13, 2022
Frequently Asked Questions: Channel and Revenue Leakage
3 Minute Read
We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
December 20, 2021
Retail Pharmacy’s Digital Transformation
3 Minute Read
As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
November 23, 2021
A Look Back at the 2021 Access Insights Conference
2 Minute Read
Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.